Enhanced in vitro DNA transfection efficiency by novel folate-linked nanoparticles in human prostate cancer and oral cancer

Journal of Controlled Release

Volumn 97, Issue 1, 2004, Pages 173-183

  Hattori, Yoshiyuki ^a   Maitani, Yoshie ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Cationic nanoparticles; Folic acid; Gene delivery; KB; LNCaP

Indexed keywords

BODY FLUIDS; CELLS; CHOLESTEROL; NANOSTRUCTURED MATERIALS; POSITIVE IONS; TUMORS;

GENE DELIVERY; HUMAN ORAL CANCER; TRANSFECTION;

DNA;

3 [N (N',N' DIMETHYLAMINOETHANE)CARBOMYL]CHOLESTEROL; CHOLESTEROL DERIVATIVE; ETHANOLAMINE DERIVATIVE; FOLATE BINDING PROTEIN; FOLATE POLYETHYLENEGLYCOL DISTEAROYLPHOSPHATIDYLETHANOLAMINE; FOLIC ACID; MESSENGER RNA; NANOPARTICLE; PLASMID DNA; POLYSORBATE 80; PROSTATE SPECIFIC MEMBRANE ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN KB; DNA DRUG COMPLEX; DNA TRANSFECTION; DRUG BINDING; DRUG DISTRIBUTION; DRUG SCREENING; DRUG STRUCTURE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUTH CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM;

CELL LINE, TUMOR; DNA; FOLIC ACID; GENE THERAPY; HUMANS; MALE; MOUTH NEOPLASMS; NANOSTRUCTURES; PARTICLE SIZE; PROSTATIC NEOPLASMS; TRANSFECTION;

EID: 2442545323     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2004.03.007     Document Type: Article

References (31)

1. Dass C.R., Burton M.A. Lipoplexes and tumours. A review. J. Pharm. Pharmacol. 51:1999;755-770
2. Treco D.A., Selden R.F. Non-viral gene therapy. Mol. Med. Today. 1:1995;314-321
3. Sternberg B., Sorgi F.L., Huang L. New structures in complex formation between DNA and cationic liposomes visualized by freeze-fracture electron microscopy. FEBS Lett. 356:1994;361-366
4. Lai E., van Zanten J.H. Real time monitoring of lipoplex molar mass, size and density. J. Control. Release. 82:2002;149-158
5. Egilmez N.K., Iwanuma Y., Bankert R.B. Evaluation and optimization of different cationic liposome formulations for in vivo gene transfer. Biochem. Biophys. Res. Commun. 221:1996;169-173
6. Nishikawa M., Huang L. Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum. Gene Ther. 12:2001;861-870
7. Reddy J.A., Dean D., Kennedy M.D., Low P.S. Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy. J. Pharm. Sci. 88:1999;1112-1118
8. Gosselin M.A., Lee R.J. Folate receptor-targeted liposomes as vectors for therapeutic agents. Biotechnol. Annu. Rev. 8:2002;103-131
9. Reddy J.A., Abburi C., Hofland H., Howard S.J., Vlahov I., Wils P., Leamon C.P. Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors. Gene Ther. 9:2002;1542-1550
10. Hofland H.E., Masson C., Iginla S., Osetinsky I., Reddy J.A., Leamon C.P., Scherman D., Bessodes M., Wils P. Folate-targeted gene transfer in vivo. Mol. Ther. 5:2002;739-744
11. Sudimack J., Lee R.J. Targeted drug delivery via the folate receptor. Adv. Drug Deliv. Rev. 41:2000;147-162
12. Ni S., Stephenson S.M., Lee R.J. Folate receptor targeted delivery of liposomal daunorubicin into tumor cells. Anticancer Res. 22:2002;2131-2135
13. Elwood P.C. Molecular cloning and characterization of the human folate-binding protein cDNA from placenta and malignant tissue culture (KB) cells. J. Biol. Chem. 264:1989;14893-14901
14. Wu M., Gunning W., Ratnam M. Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix. Cancer Epidemiol. Biomark. Prev. 8:1999;775-782
15. Shen F., Ross J.F., Wang X., Ratnam M. Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity. Biochemistry. 33:1994;1209-1215
16. Ratnam M., Marquardt H., Duhring J.L., Freisheim J.H. Homologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNA. Biochemistry. 28:1989;8249-8254
17. Ross J.F., Wang H., Behm F.G., Mathew P., Wu M., Booth R., Ratnam M. Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia. Cancer. 85:1999;348-357
18. Wang H., Ross J.F., Ratnam M. Structure and regulation of a polymorphic gene encoding folate receptor type gamma/gamma'. Nucleic Acids Res. 26:1998;2132-2142
19. Wang X., Jansen G., Fan J., Kohler W.J., Ross J.F., Schornagel J., Ratnam M. Variant GPI structure in relation to membrane-associated functions of a murine folate receptor. Biochemistry. 35:1996;16305-16312
20. Gao X., Porter A.T., Grignon D.J., Pontes J.E., Honn K.V. Diagnostic and prognostic markers for human prostate cancer. Prostate. 31:1997;264-281
21. Holm J., Hansen S.I., Hoier-Madsen M. High-affinity folate binding in human prostate. Biosci. Rep. 13:1993;99-105
22. Silver D.A., Pellicer I., Fair W.R., Heston W.D., Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin. Cancer Res. 3:1997;81-85
23. Pinto J.T., Suffoletto B.P., Berzin T.M., Qiao C.H., Lin S., Tong W.P., May F., Mukherjee B., Heston W.D. Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells. Clin. Cancer Res. 2:1996;1445-1451
24. Gabizon A., Horowitz A.T., Goren D., Tzemach D., Mandelbaum-Shavit F., Qazen M.M., Zalipsky S. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. Bioconjug. Chem. 10:1999;289-298
25. Zabner J. Cationic lipids used in gene transfer. Adv. Drug Deliv. Rev. 27:1997;17-28
26. Escriou V., Ciolina C., Lacroix F., Byk G., Scherman D., Wils P. Cationic lipid-mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lipopolyamine/DNA complexes. Biochim. Biophys. Acta. 1368:1998;276-288
27. Reimer D.L., Kong S., Monck M., Wyles J., Tam P., Wasan E.K., Bally M.B. Liposomal lipid and plasmid DNA delivery to B16/BL6 tumors after intraperitoneal administration of cationic liposome DNA aggregates. J. Pharmacol. Exp. Ther. 289:1999;807-815
28. Zelphati O., Nguyen C., Ferrari M., Felgner J., Tsai Y., Felgner P.L. Stable and monodisperse lipoplex formulations for gene delivery. Gene Ther. 5:1998;1272-1282
29. Sakaeda T., Hirano K. Effect of composition on biological fate of oil particles after intravenous injection of O/W lipid emulsions. J. Drug Target. 6:1998;273-284
30. Liu F., Yang J., Huang L., Liu D. Effect of non-ionic surfactants on the formation of DNA/emulsion complexes and emulsion-mediated gene transfer. Pharm. Res. 13:1996;1642-1646
31. Kim T.W., Chung H., Kwon I.C., Sung H.C., Jeong S.Y. Optimization of lipid composition in cationic emulsion as in vitro and in vivo transfection agents. Pharm. Res. 18:2001;54-60